Experiments on breast cancer cells demonstrated that CAII is upregulated in the highly tumorigenic MDA-MB-231 cell line when the cells are exposed to the chemotherapeutic drug doxorubicin (Mallory et al., 2005). This evidence concerns the gene CA2 and breast cancer.